with the growing number of elderly people in the population and the high prevalence of diabetes in the world, there are more and more elderly patients with diabetes type II. unfortunately, the management of diabetes amongst the elderly is not easy ever. the elderly are heterogeneous.
The episodes of hypoglycemia and hyperglycemia are most frequent and dangerous for older patients. the morbidity, functional impairment, and the support system available that can influence the management of the disease. the target for glycemic control in elderly patients should be based on individual conditions. although the number of clinical trials for the treatment of diabetes type II in the elderly is limited, the organizations have issued guidelines or statements on diabetes type II in the elderly. there are approved therapies or drugs for the control of this disease, but we should be more consideration for the elderly patients with type 2 diabetes.
The study revealed that the injection of people with the hormone known as FGF21 leads to weight loss and increased insulin sensitivity for more than a year.
Confirmed the newspaper "Daily Mail" report translated At "urgent" - that FGF21 hormone leads to weight loss by enhancing energy levels, and increasing activity of the individual, the hormone also raises body temperature; what causes the burning of calories.
The insulin resistance has reduced the ability of cells to respond to the hormone that transports glucose from the bloodstream; where this case is linked to the occurrence with the onset of type II diabetes disease. Obesity increases the risk of this chronic disease.
Researchers from the Autonomous University of Barcelona conducted the experience of feeding adult rate either a normal or high - fat diet for 10 weeks and found that there is an increase in the weight increase of 72% as a result of high - fat meals. The regular meals increase the size only of 27%.
The researchers then injected the rate that underwent meals fatty hormone FGF21, the result was a 10% loss of weight, without any change in the density or bone size have with a low proportion of insulin resistance in the body.
Reference :
Impact of FGF21 on glycemic control
No comments:
Post a Comment